eFFECTOR Therapeutics, Inc. (EFTR)
NASDAQ: EFTR · IEX Real-Time Price · USD
1.810
-0.040 (-2.16%)
At close: Apr 25, 2024, 4:00 PM
1.840
+0.030 (1.66%)
After-hours: Apr 25, 2024, 7:57 PM EDT
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $6.67 million as of April 25, 2024. Its market cap has decreased by -60.74% in one year.
Market Cap
6.67M
Enterprise Value
8.85M
1-Year Change
-60.74%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since January 8, 2021, eFFECTOR Therapeutics's market cap has decreased from $175.80M to $6.67M, a decrease of -96.20%. That is a compound annual growth rate of -62.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 6.80M | -5.56% |
Apr 23, 2024 | 7.20M | 9.09% |
Apr 22, 2024 | 6.60M | 4.76% |
Apr 19, 2024 | 6.30M | -4.55% |
Apr 18, 2024 | 6.60M | -5.71% |
Apr 17, 2024 | 7.00M | -4.11% |
Apr 16, 2024 | 7.30M | 2.82% |
Apr 15, 2024 | 7.10M | -7.79% |
Apr 12, 2024 | 7.70M | -6.10% |
Apr 11, 2024 | 8.20M | -5.75% |
Apr 10, 2024 | 8.70M | 2.35% |
Apr 9, 2024 | 8.50M | 7.59% |
Apr 8, 2024 | 7.90M | -15.05% |
Apr 5, 2024 | 9.30M | -14.68% |
Apr 4, 2024 | 10.90M | -82.04% |
Apr 3, 2024 | 60.70M | 6.87% |
Apr 2, 2024 | 56.80M | -1.73% |
Apr 1, 2024 | 57.80M | 8.85% |
Mar 28, 2024 | 53.10M | 7.06% |
Mar 27, 2024 | 49.60M | 4.20% |
Mar 26, 2024 | 47.60M | 33.71% |
Mar 25, 2024 | 35.60M | 11.60% |
Mar 22, 2024 | 31.90M | -4.78% |
Mar 21, 2024 | 33.50M | 0.90% |
Mar 20, 2024 | 33.20M | 4.73% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tenax Therapeutics | 6.97M |
Adial Pharmaceuticals | 6.93M |
Clever Leaves Holdings | 6.90M |
Cadrenal Therapeutics | 6.86M |
Plus Therapeutics | 6.84M |
Enveric Biosciences | 6.81M |
Kineta | 6.80M |
Assure Holdings | 6.57M |